Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EPI-MAX

K-Number: K041059 · 2005-05-17

Decision Date2005-05-17
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

EPI-MAX is the device name listed in this FDA 510(k) record. The listed applicant is Dermagenics, Inc.. It received FDA 510(k) clearance on 2005-05-17 under 510(k) number K041059. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EPI-MAX?

EPI-MAX is a medical device that received FDA 510(k) clearance on 2005-05-17. The listed applicant is Dermagenics, Inc.. The 510(k) number is K041059.

When did EPI-MAX receive FDA 510(k) clearance?

EPI-MAX received FDA 510(k) clearance on 2005-05-17, under 510(k) number K041059.

Who is the listed applicant for EPI-MAX?

The FDA 510(k) record lists Dermagenics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EPI-MAX?

The FDA product code for EPI-MAX is FRO. This falls under the Anesthesiology category.

Related Devices (Code: FRO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑